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Serotonin (5-hydroxytryptamine or 5-HT) is an important neurotransmitter regulating a
wide range of physiological and pathological functions via activation of heterogeneously
expressed 5-HT receptors. The 5-HT7 receptor is one of the most recently described
members of the 5-HT receptor family. Functionally, 5-HT7 receptor is associated with
a number of physiological and pathological responses, including serotonin-induced
phase shifting of the circadian rhythm, control of memory as well as locomotor and
exploratory activity. A large body of evidence indicates involvement of the 5-HT7
receptor in anxiety and depression, and recent studies suggest that 5-HT7 receptor
can be highly relevant for the treatment of major depressive disorders. The 5-HT7
receptor is coupled to the stimulatory Gs-protein, and receptor stimulation results
in activation of adenylyl cyclase (AC) leading to a rise of cAMP concentration.
In addition, this receptor is coupled to the G12-protein to activate small GTPases
of the Rho family. This review focuses on molecular mechanisms responsible for
the 5-HT7 receptor-mediated signaling. We provide detailed overview of signaling
cascades controlled and regulated by the 5-HT7 receptor and discuss the functional
impact of 5-HT7 receptor for the regulation of different cellular and subcellular
processes.
Keywords: serotonergic signaling, G-protein coupled receptors, serotonin 5-HT7 receptor, heterotrimeric G-protein,
oligomerization, palmitoylation
GENERAL PRINCIPLES OF G-PROTEIN COUPLED RECEPTOR
SIGNALING
G-protein coupled receptors (GPCRs) represent the largest and
most diverse superfamily of transmembrane receptors divided
into five different families: rhodopsin, secretin, glutamate, adhe-
sion and frizzled receptors (Bjarnadóttir et al., 2006). Initial
studies with first discovered GPCRs, bovine rhodopsin and
β2 adrenergic receptor, arouse great interest in the field of
GPCRs, whose structures and functions became a subject of
extensive research (Nathans and Hogness, 1983; Dixon et al.,
1986). All these receptors function as signal-transducers by trans-
lating extracellular stimuli into intracellular responses result-
ing in multiple physiological as well as pathophysiological
responses (Thompson et al., 2008). All known GPCRs consist
of an extracellular amino-terminus, seven membrane-spanning
α-helices (for which reason they are often referred to as 7 trans-
membrane receptors), and an intracellular carboxyl-terminus.
Hence GPCR activity is induced by many different ligands,
the mechanism of sensing ligands and transducing signals are
highly variable (reviewed in Kristiansen, 2004). According to
the “allosteric ternary complex model”, GPCRs exist in equi-
librium between an inactive and active state (Christopoulos
and Kenakin, 2002), explaining the agonist-independent, con-
stitutive activity of some receptors (Seifert and Wenzel-Seifert,
2002).
HETEROTRIMERIC G-PROTEINS
Heterotrimeric G-proteins are the main downstream effectors of
GPCRs acting as molecular switches by turning on intracellular
downstream signaling cascades. They consist of three subunits,
α, β and γ and are divided into four subgroups according to
the structural and functional similarities of the Gα subunit. The
members of the stimulatory Gαs family stimulate adenylyl cyclases
(ACs), whereas inhibitory Gαi proteins inhibit ACs. The Gαq
class of G-proteins couples to phospholipase Cβ (PLCβ), while
Gα12 family members activate Rho guanine-nucleotide exchange
factors (Rho GEFs; Kristiansen, 2004). To date at least 16 different
genes encoding Gα subunits, 5 genes encoding Gβ subunits and
12 different genes encoding Gγ subunits have been discovered.
Although not all subunits do interact with each other, the diversity
of heterotrimeric G-proteins is still enormous, and this represents
an additional level of complexity by the regulation of multiple
signaling pathways (Cabrera-Vera et al., 2003).
Heterotrimeric G-proteins become activated by GPCRs via
complex conformational changes, which are also facilitated by
Gβγ dimers (Ford et al., 1998). Upon discovery of the het-
erotrimeric G-proteins, they were thought to conduct signals
exclusively via Gα-subunits. Later on, Gβγ dimer has also been
shown to directly modulate downstream effectors. First identi-
fied downstream target of Gβγ dimer was G-protein coupled
inward rectifier potassium (GIRK) channel (Logothetis et al.,
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1987). Nowadays, a list of downstream effectors regulated by
Gβγ dimers is permanently extending (Woehler and Ponimaskin,
2009).
In parallel with this classical G-protein mediated GPCR sig-
naling, non-classical (G-protein independent) signaling became
obvious during the last decade. This type of signaling will be also
discussed below.
G-PROTEIN INDEPENDENT SIGNALING
Beside the canonical GPCR signaling pathways via heterotrimeric
G-proteins, GPCRs can participate in non-canonical, G-protein
independent signaling. Main players of the G-protein indepen-
dent signaling are arrestins - a small family of cytosolic adaptor
proteins consisting of four members (Krupnick and Benovic,
1998). In contrast to arrestin 1 and arrestin 4 (X arrestin), which
are primary involved in adaption processes of opsins in rods
or cones, arrestin 2 and 3 (β-arrestin 1 and 2) are ubiquitously
expressed and can interact with different GPCRs (Lefkowitz and
Shenoy, 2005). Shortly after receptor stimulation, the C-terminal
tail of a GPCR often becomes substrate for the phosphoryla-
tion by G-protein coupled receptor kinases (GRKs; Gehret and
Hinkle, 2010). Phosphorylated receptors display a high affinity for
β-arrestin 1 and 2, which hinder interactions between receptor
and heterotrimeric G-protein resulting in desensitization and
damping of G-protein dependent signaling (Perry et al., 2002).
However, differently than thought at the beginning, arrestins
not only switch-off the GPCR-signaling, but can also lead to
the activation of alternative signaling pathways. Thus, β-arrestins
serve as a signaling hub, linking activated GPCRs to multiple
(G-protein independent) signaling pathways such as receptor
trafficking as well as in extending GPCR mediated signaling to
non-receptor tyrosine kinases (nRTKs) like proto-oncogene c-Src
(c-Src) and mitogen-activated protein kinases (MAPK) signaling
pathways.
5-HT7 RECEPTOR: PHYSIOLOGICAL FUNCTIONS AND
DISTRIBUTION IN THE BRAIN
The 5-HT7 receptor is one of the most recently discovered mem-
bers of the serotonin receptor family, which was cloned in 1993
independently by researchers in three laboratories (Bard et al.,
1993; Lovenberg et al., 1993; Ruat et al., 1993). The 5-HT7 recep-
tor gene is located on human chromosome 10q23.3-q24.3 with
an open reading frame containing 1335 base pairs and encoding a
protein of 445 amino acids (Bard et al., 1993). The 5-HT7 receptor
is broadly expressed in the central nervous system including
spinal cord (Dogrul and Seyrek, 2006), thalamus, hypothalamus,
hippocampus, prefrontal cortex, and the amygdala where it is
expressed in both neurons and glial cells (Hedlund and Sutcliffe,
2004; Thomas and Hagan, 2004; Russo et al., 2005). Significant
density of 5-HT7 receptor was observed in raphe nuclei area.
In contrast, receptor expression level detected in putamen and
cerebellum was relatively low (Horisawa et al., 2013). The 5-HT7
receptor is also expressed in the suprachiasmatic nucleus, and one
of the first functions proposed for the 5-HT7 receptor was the
regulation of sleep/wake cycles (Lovenberg et al., 1993). Func-
tional analysis demonstrated association of the 5-HT7 receptor
with central processes such as learning and memory, including
specific aspects of hippocampus-dependent information process-
ing (Hedlund and Sutcliffe, 2004; Ballaz et al., 2007; Eriksson
et al., 2008; Gasbarri et al., 2008; Hedlund, 2009). Moreover, 5-
HT7 receptor can be implicated in several neurological diseases
(Hedlund and Sutcliffe, 2004; Thomas and Hagan, 2004). It has
been shown that pharmacological blockade or knock-down of the
5-HT7 receptor induces antidepressant-like behavior in animal
models (Guscott et al., 2005; Hedlund et al., 2005; Wesołowska
et al., 2007). In addition, certain antidepressants may act directly
on the 5-HT7 receptor (Mullins et al., 1999), suggesting this recep-
tor as a novel target by the treatment of depression (Hedlund,
2009; Mnie-Filali et al., 2009). Analysis of mRNA expression level
revealed that the amount of 5-HT7 gene transcripts in the dorso-
lateral prefrontal cortex of schizophrenic patients was increased,
demonstrating that 5-HT7 receptor can also be associated with
schizophrenia (East et al., 2002; Pouzet et al., 2002; Ikeda et al.,
2006).
So far, three splice variants of the 5-HT7 receptor have been
identified in human, including 5-HT7(a), 5-HT7(b), 5-HT7(d),
three in mouse - 5-HT7(a), 5-HT7(b), 5-HT7(d), and four in rat -
5-HT7(a), 5-HT7(b), 5-HT7(c), 5-HT7(e) (Heidmann et al., 1997;
Liu et al., 2001). These splice variants differ only in their short
carboxyl-terminal amino acid sequence. Receptor isoforms have
altered patterns of tissue distribution, while no difference in their
pharmacological properties and coupling to ACs was observed
(Heidmann et al., 1997, 1998; Krobert et al., 2001). The human
5-HT7(d) receptor represents an exception, because this isoform
possesses a differential pattern of receptor internalization which
can affect receptor-mediated signaling (Guthrie et al., 2005).
In this regard, 5-HT7(d) receptor was constitutively internalized
in the absence of agonist suggesting that its carboxyl-terminal
tail, which is the longest among known human 5-HT7 recep-
tor isoforms, may contain a motif that interacts with cellular
transport machinery that is distinct from 5-HT7(a) and 5-HT7(b)
receptors.
GαS SIGNALING MEDIATED BY THE 5-HT7 RECEPTOR
The canonical signaling pathway of the 5-HT7 receptor is acti-
vation of Gs-protein which in turn can activate different AC
isoforms (Shen et al., 1993). ACs show a unique tissue distri-
bution as well as regulatory properties (Krupinski et al., 1989;
Bakalyar and Reed, 1990; Premont et al., 1996). In vitro, all
known AC isoforms are sensitive to the Gs activation (Cooper
et al., 1995; Taussig and Gilman, 1995; Sunahara et al., 1996).
In contrast, it has been demonstrated that Ca2+/calmodulin-
stimulated neural-specific isoforms AC1 and AC8 are insensitive
to Gs in vivo (Impey et al., 1994; Wayman et al., 1994; Nielsen
et al., 1996), and that 5-HT7(a) receptor isoform can stimulate
AC1 and AC8 by increasing intracellular Ca2+ concentration
(Baker et al., 1998). The coupling between 5-HT7 receptor and
Gs-protein results in increased AC activity leading to produc-
tion of cAMP, which in turn activates protein kinase A (PKA)
thereby inducing phosphorylation of different target proteins
(Figure 1). This results in activation of multiple downstream sig-
naling cascades, including Ras-dependent and Rap1-independent
activation of the neuroprotective extracellular signal-regulated
kinases (ERK) and Akt (protein kinase B) pathways (Errico et al.,
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FIGURE 1 | Schematic representation of signaling pathways regulated by
the 5-HT7 receptor. Effects mediated by Gs-proteins are in the left section.
Summary of the G12-mediated signaling processes is shown in the right
section. Abbreviations: GIRK—G-protein coupled inward rectifier potassium
channel; AC—adenylyl cyclase; cAMP—cyclic adenosine monophosphate;
PKA—protein kinase A; ERK—extracellular signal-regulated kinases;
Akt—protein kinase B, Hsp90—heat shot shock protein 90; ERM—proteins of
the ezrin-radixin-moesin family; GEF—guanine-nucleotide exchange factor
(represented by the leukemia-associated RhoGEF LARG and p115Rho);
nRTKs—non-receptor tyrosine kinases; AKAPs—A-kinase anchoring proteins;
ZO—zona occludens proteins; SRF—serum response factor; SRE—serum
response element.
2001; Johnson-Farley et al., 2005). Noteworthy, 5-HT7 receptor-
mediated activation of Akt requires increases both in [cAMP]
and intracellular [Ca2+], while activation of ERK is inhibited
by Ca2+ (Figure 1). However, neither an influx of extracellular
Ca2+ nor release of intracellular Ca2+ stores was required for 5-
HT7 receptor-mediated activation of ERK in cultured primary
hippocampal neurons (Lin et al., 2003). The authors of this study
also demonstrated that increase in cAMP concentration causes
activation of ERK in neurons via a pathway independent of PKA
and Raf-1 (Li et al., 1991; Kyriakis et al., 1992). It is widely
accepted, that intracellular pathways regulating ERK1/2 and Akt
signaling are involved in actin filament reorganization. On the
other hand, studies with LM2 cells, which are able to invade
into the lung tissue in vivo, revealed no significant inhibition
in cell motility after Ras-ERK pathway blockade, while PI3K
pathways was critically involved in regulation of motility of LM2
cells (Choi and Helfman, 2014). It has been also shown that
activation of PI3K activity alone is sufficient to remodel actin
filaments and to increase cell migration through the activation of
Akt in chicken embryo fibroblast (Qian et al., 2004). Thus, 5-HT7
receptor-mediated activation of Gs-protein can be involved in the
activation of effector molecules regulating the cellular motility
and cytoskeleton formation.
Gα12 SIGNALING MEDIATED BY THE 5-HT7 RECEPTOR
In our previous studies we have demonstrated that 5-HT7 recep-
tor is coupled not only to the Gs-protein, but can also activate
G12-protein (Figure 1; Kvachnina et al., 2005; Kobe et al., 2012).
The G12-proteins have been shown to activate multiple
signaling pathways, and their prominent downstream effec-
tors are members of the Rho family of small GTPases (Rho,
Rac, and Cdc42). The G12-protein can modulate the activity
of Rho GTPases by activation of guanine-nucleotide exchange
factor (GEF) p115Rho which was the first identified down-
stream effector of Gα12 proteins (Hart et al., 1998; Kozasa
et al., 1998). Later on, plethora of additional downstream
targets of G12-proteins has been discovered. In addition to
other RhoGEFs, such as leukemia-associated RhoGEF (LARG)
and RhoGEF homologs in Caenorhabditis elegans, regula-
tor of G-protein signaling (RGS) family members, proteins
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of the ezrin-radixin-moesin (ERM) family, nRTKs, protein
phosphatases, A-kinase anchoring proteins (AKAPs), zona occlu-
dens proteins and heat shot shock protein 90 (Hsp90) have
been identified to directly interact with heterotrimeric G12-
protein (Figure 1; Hiley et al., 2006; Kelly et al., 2007).
The Gα12 subunit can also interact with C-terminal parts
of cadherins leading to release of β-catenin into cytoplasm
and nucleus, thus triggering gene transcription (Meigs et al.,
2001).
In case of 5-HT7 receptor, it has been reported that receptor-
mediated stimulation of G12-protein results in Rho-dependent
activation of a transcription factor, serum response factor (SRF),
which binds to the serum response element (SRE; Figure 1).
Noteworthy, stimulation of 5-HT7 receptor led to the dose-
dependent increase in SRE-driven gene expression even in the
presence of a PKA-inhibitor or pertussis toxin (PTX), suggesting a
receptor-mediated SRE activation in a PKA-independent manner
(Kvachnina et al., 2005). Recent findings also elucidated Rho-
independent mechanism of Gα12-mediated SRE activation via
Hsp90 (Figure 1; Montgomery et al., 2014). Interaction between
Gα12 and Hsp90 might also be critically involved in a selective
transport of the G12-protein to the lipid rafts (Waheed and Jones,
2002).
Detailed analysis of 5-HT7 receptor-mediated signaling
revealed that coupling of receptor to the heterotrimeric G12-
protein selectively activates both RhoA and Cdc42 (Kvachnina
et al., 2005), suggesting existence of cross-talk between Cdc42 and
RhoA pathways. This might be mediated via convergent actions of
these GTPases on the downstream effector myosin (Manser et al.,
1994; Amano et al., 1996). Alternatively, Cdc42 and RhoA may
function in a hierarchical cascade wherein Cdc42 downregulates
RhoA activity (Figure 1; Li et al., 2002).
In neuroblastoma cells, agonist-dependent activation of
recombinant 5-HT7 receptor induces pronounced filopodia for-
mation via a Cdc42-mediated pathway paralleled by the RhoA-
induced cell rounding (Kvachnina et al., 2005). Stimulation of the
5-HT7R/G12 signaling pathway in cultured hippocampal neurons
promotes formation of dendritic spines and accelerates synapto-
genesis, leading to enhanced spontaneous synaptic activity (Kobe
et al., 2012). Morphogenic action of 5-HT7 receptor was further
confirmed in experiments with striatal and cortical neuronal
cultures (Speranza et al., 2013). In this study authors observed
pronounced neurite outgrowth after specific activation of 5-HT7
receptor and demonstrated involvement of ERK and Cdk5 in this
process, presuming both proteins to be downstream signaling
molecules of Gα12 (Speranza et al., 2013).
Noteworthy that 5-HT7/G12 signaling in hippocampus
undergoes strong developmental regulation. In organotypic
hippocampal cultures from juvenile mice, 5-HT7R/G12 signaling
potentiates formation of dendritic spines, increases the basal neu-
ronal excitability and modulates synaptic plasticity. In contrast, in
older neuronal preparations, stimulation of 5-HT7 receptor had
no effect on neuronal morphology, synaptogenesis and synaptic
plasticity (Kobe et al., 2012). Accordingly, the expression level
of both 5-HT7 receptor and G12-protein in the hippocampus
is progressively decreased during postnatal development (Kobe
et al., 2012). Thus, 5-HT-induced activation of the 5-HT7R/G12
signaling pathways and the consequent reorganization of the
dendritic morphology appear to be a part of the molecular cas-
cade required for the growth of new synapses and the formation
of initial neuronal networks, which then become the subject of
activity-dependent structural and functional plasticity (Citri and
Malenka, 2008; Ibata et al., 2008).
HOMO- AND HETERODIMERIZATION OF 5-HT7 RECEPTORS
G-protein-coupled receptors were initially assumed to exist and
function as monomeric units that interact with corresponding G-
proteins in 1:1 stoichiometry. Recent studies revealed the capa-
bility of GPCRs to form oligomers (Devi, 2001; Bulenger et al.,
2005), and it is now widely accepted that homo- and heterodimer-
ization can represent an additional mechanism regulating GPCR-
mediated signaling.
Pharmacological analysis in combination with BRET
experiments demonstrated that 5-HT7 receptor can form
homooligomers in recombinant system (Teitler et al., 2010;
Figure 1). Existence of 5-HT7 receptor homodimers has also been
shown in primary cultures of rat cortical astrocytes (Smith et al.,
2011). Homooligomerization of 5-HT7 receptor at the single-cell
level has been further confirmed using two different FRET assays
(Renner et al., 2012).
By combined application of biochemical and biophysical
approaches we have recently demonstrated that 5-HT7 receptors
can form heterodimers with 5-HT1A receptors both in vitro and
in vivo (Renner et al., 2012; Figure 1). From the functional point
of view, heterodimerization decreases Gi-protein coupling of 5-
HT1A receptor and attenuates receptor-mediated activation of G-
protein-gated potassium (GIRK) channels, without substantial
changes in the coupling of 5-HT7 receptor to the Gs-protein.
Moreover, heterodimerization significantly facilitated internaliza-
tion of 5-HT1A receptor, while internalization kinetics of 5-HT7
receptor was decelerated upon heterodimerization (Renner et al.,
2012).
PALMITOYLATION OF THE 5-HT7 RECEPTOR
Many signaling molecules involved in GPCR-mediated signaling
are modified by post-translational modifications (Escribá et al.,
2007), such as phosphorylation, ubiquitination, glycosylation,
palmitoylation and others. The experiments with mutations of
two predicted N-glycosylation sites in 5-HT7(a) receptor (N5Q
and N66Q) revealed, that 5-HT7(a) receptor glycosylation neither
influence the binding of 5-CT agonist to the receptor, nor the
potency or efficacy with respect to activation of second messenger
cascades, although a decrease in receptor density is apparent for
the non-glycosylated receptor (Gellynck et al., 2012). To date,
no data about the phosphorylation or ubiquitination of 5-HT7
receptor are available.
Covalent attachment of long chain saturated fatty acids (i.e.,
palmitate) to cysteine residue(s) within the protein via a labile
thioester linkage (S-palmitoylation) represents a widespread post-
translational modification of GPCRs since approximately 80% of
all known receptors contain the potentially palmitoylable cysteine
residue(s) downstream of their seventh transmembrane domain
(Escribá et al., 2007). GPCR palmitoylation is involved in the
modulation of different receptor functions from coupling to
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FIGURE 2 | Hypothetical model for the regulation of 5-HT7 receptor
activity by dynamic palmitoylation. This model suggests existence of
two different receptor populations: Palmitoylated receptors with two
additional intracellular C-terminal loops (left) and non-palmitoylated
receptors with no intracellular C-terminal loops (right). These
populations exist in dynamic equilibrium regulated by basal or
agonist-promoted palmitate turnover. Depalmitoylation results in
significant increase of the receptor’s capacity to convert from the
inactive (R) to the active (R*) form in the absence of an agonists.
Palmitoylated receptor shows activation of both Gαs- and Gα12-proteins
(left). Non-palmitoylated receptor possesses increased
agonist-independent, constitutive activity (R*) towards Gαs-mediated
signaling, while basal receptor-mediated activation of Gα12-protein is
unaltered (right).
G-proteins and regulation of endocytosis to receptor phospho-
rylation and desensitization. Also the serotonin receptors repre-
sent potential substrates for palmitoylation, and palmitoylation
was experimentally demonstrated for 5-HT1A, 5-HT1B, 5-HT4
and 5-HT7 receptors (reviewed in Gorinski and Ponimaskin,
2013).
The mouse 5-HT7 receptor has been shown to undergo
dynamic palmitoylation in an agonist-dependent manner after
expression in Sf.9 insect cells. Mutation analysis demonstrated
that cysteines located in the C-terminal receptor domain at posi-
tions 404, 438 and 441 represent the main potential palmitoy-
lation sites (Figure 2). Although these cysteine residues were
responsible for the attachment of more than 90% of the receptor-
bound palmitate, palmitoylation of 5-HT7 receptor was still not
restricted to its C-terminus, pointing to the existence of additional
acylation site(s) within the receptor.
Functional analysis of palmitoylation-deficient mutants
revealed that agonist-induced activation of Gs- and G12-proteins
was unaffected. However, mutation of the Cys404 either alone or
in combination with Cys438/Cys441 significantly increased the
agonist-independent, Gs-mediated constitutive 5-HT7 receptor
activity, while the activation of G12-protein was not affected
(Figure 2; Kvachnina et al., 2009). Generally, these data suggest
that palmitoylation of 5-HT7 receptor might be directly involved
in the isomerization of the receptor from the inactive to the
active form in the absence of agonists. This transformation
can be realized by dictating the conformation of receptor’s
flexible cytoplasmic loops which might be involved either in
the receptor/Gs-protein recognition or in Gs-protein binding
and/or receptor-mediated Gs-protein activation (Figure 2).
In combination with the previous findings on the functional
role of 5-HT4 receptor palmitoylation (Ponimaskin et al.,
2002, 2005), this observation suggests that palmitoylation can
represent a general feature regulating constitutive receptor
activity. Moreover, in case of 5-HT7 receptor (which is coupled
to both, Gs- and G12-proteins) dynamic palmitoylation can
represent a molecular mechanism responsible for selective Gs- or
G12-mediated signaling.
PHARMACOLOGICAL PROPERTIES OF 5-HT7 RECEPTOR
During the last decade, several selective agonists and antago-
nists for 5-HT7 receptors have been developed and applied to
investigate its pharmacology. Pharmacological analysis revealed
that application of risperidone, 9-OH-risperidone, methiothepin,
bromocryptine, lisuride, and metergoline resulted in irreversible
inhibition of the recombinant 5-HT7 receptor expressed in
HEK-293 cells (Smith et al., 2006; Knight et al., 2009). In
contrast, action of other potent 5-HT7 receptor antagonists,
including clozapine, mesulergine, penfluridol, amperozide and
cinanserin is reversible and can be washed out (Knight et al.,
2009). In other study receptor-inactivating properties of risperi-
done, 9-OH-risperidone, bromocriptine, methiothepin, meter-
goline, and lisuride have been demonstrated. Noteworthy that
methiothepin and bromocriptine maximally inhibited forskolin-
stimulated adenylate cyclase, whereas the other drugs produced
partial inhibition, indicating the drugs are inducing slightly differ-
ent inactive conformations of the 5-HT7 receptor (Toohey et al.,
2009). Nowadays, the highly specific 5-HT7 receptor antagonist
SB-269970 (pK i = 8.9 nM) is a mostly used receptor antago-
nist for in vitro and in vivo studies (Kobe et al., 2012; Renner
et al., 2012; Tokarski et al., 2012; Vasefi et al., 2013; Guseva
et al., 2014; Monti and Jantos, 2014). For the pharmacological
activation of the receptor, a high-affinity receptor agonist 5-CT
(IC50 = 0.83 nM, EC50 13 nM) is widely used in a numerous
in vitro and in vivo studies (Guscott et al., 2003; Kobe et al.,
2012; Vasefi et al., 2013). However, 5-CT is known to activate
5-HT1A, 5-HT1B, and 5-HT1D receptors. Therefore, analysis of 5-
HT7 receptor functions by 5-CT requires parallel application of 5-
HT1A/1B/1D receptor antagonists. Recently, various novel selective
agonists such as AS-19, LP-44, LP-12, LP-211 and E-55888 were
developed in addition to 5-CT (reviewed in Di Pilato et al., 2014).
Amongst them two novel agonists, LP-211 and LP-378, have been
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investigated in regard to exploratory motivation, anxiety-related
profiles, and spontaneous circadian rhythm (Adriani et al., 2012).
The authors have shown that three- to four-fold dosage of LP-
378 was necessary to induce the same effect as LP-211. The latest
studies, both in vitro and in vivo, indicated LP-211 (K i = 379 nM)
as a more specific 5-HT7 receptor agonist with great potential
for future investigations (Speranza et al., 2013; Monti and Jantos,
2014).
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